| European withdrawal of appetite suppressants. | |
| | |
MedLine Citation:
|
PMID: 12760442 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The temporary delicensing of the centrally acting appetite suppressants (first in April 2000, then in May 2001) by the European Commission's Committee on Proprietary Medical Products was premature and possibly unjustified. While their ultimate fate is awaited, the European Drugs Evaluation Agency declined to release the information on which its withdrawal advice was based. |
| | |
Authors:
|
H G Kinnell |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Obesity reviews : an official journal of the International Association for the Study of Obesity Volume: 4 ISSN: 1467-7881 ISO Abbreviation: Obes Rev Publication Date: 2003 May |
Date Detail:
|
Created Date: 2003-05-22 Completed Date: 2003-08-26 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 100897395 Medline TA: Obes Rev Country: England |
Other Details:
|
Languages: eng Pagination: 79-81 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Appetite Depressants
/
adverse effects* Europe Humans Legislation, Drug |
| Chemical | |
Reg. No./Substance:
|
0/Appetite Depressants |
| Comments/Corrections | |
Comment In:
|
Obes Rev. 2003 May;4(2):75
[PMID:
12760440
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Left-sided facial nevus with contralateral leptomeningeal angiomatosis in a child with Sturge-Weber ...
Next Document: Should we recommend low-fat diets for obesity?